A systematic review and meta‐analysis of eating disorder preventative interventions in schools
Abstract
Abstract Objective Adolescents are particularly susceptible to developing an eating disorder (ED). Therefore, schools are in a unique position to assist in the prevention of EDs for this vulnerable group. To ascertain the current evidence‐base for school‐based ED prevention efforts, we conducted a systematic review and meta‐analysis of randomised controlled trials that delivered a school‐based ED prevention intervention and assessed the impact these interventions had on ED symptomatology. Method Electronic databases (PsycINFO, MEDLINE, EMBASE, Web of Science, Scopus and CENTRAL) were searched for published randomised controlled trials of school‐based ED prevention interventions from inception to 2024. Twelve studies from 11 articles were identified with 7935 participants (mean ages ranging from 12 to 17). Of these studies, six were included in meta‐analyses. Results Media literacy and dissonance‐based interventions reported small to medium effects for ED symptomatology compared to controls at post‐intervention. At three‐to‐six‐month follow‐up, intervention groups reported small negative to medium‐sized positive effects compared to control groups on eating disorder symptomatology. Conclusions While school‐based ED prevention interventions can effectively reduce ED symptomatology post‐intervention, the programs analysed in this review do not reliably demonstrate effectiveness across groups and time. Future research should build upon current interventions to increase…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 7,935 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.